can you still compound semaglutide Compounded Safety: What Should Know Compounded semaglutide is not the

These head-to-head trials will provide important comparative data for clinical decision-making as the pipeline continues to mature

This is where GLP-1 medications change the narrative

The Food and Drug Administration approved Zepbound for use by adults with a body mass index, or BMI, of at least 30 or a BMI of 27 or more if a patient also has another weight-related condition, such as high blood pressure, heart disease or obstructive sleep apnea

28 Overall, we see significant growth opportunities within the GLP-1 category, driven by the expansion of supply to meet the high demand and anticipated approvals for new disease categories.